Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Texas Southwestern Medical Center
Age
16–45
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
A glucose value of ≥140 mg/dl on a 50-gram oral glucose loading test by plasma at gestational age between 24 weeks 0 days and 27 weeks 6 days based on clinical information
An Abnormal 3-hour oral glucose tolerance test with a fasting glucose of ≤105 mg/dl
Gestational age of less than or equal to 28 weeks and 0 days at the time of consent/randomization
Singleton gestation
You may not be if
Established pregestational diabetes
Abnormal gestational diabetes testing (≥140) prior to 24 weeks 0 days of gestation. Women who have a negative glucose loading test (\<140mg/dl) before 24 weeks may still be considered for this study if they present again for glucose tolerance testing between 24 and 27 weeks.
Multiple gestations
Known major fetal anomaly or fetal demise
Any renal disease with serum creatinine of \>1.0
Known liver disease such as hepatitis
Maternal or fetal conditions likely to require imminent or very preterm delivery such as preeclampsia, preterm premature rupture of the membranes, preterm labor, and intrauterine fetal growth restriction
Known hypersensitivity or allergic reaction to Glyburide
